Skip to main content
NBY logo
NBY
(NYSEAMERICAN)
NovaBay Pharmaceuticals, Inc.
$1.55-- (--)
Loading... - Market loading

NovaBay Pharmaceuticals (NBY) Company Profile

Complete business overview, executive team, trading details, and corporate information.

NovaBay Pharmaceuticals, Inc.
NBYNYSEAMERICANHealthcareBiotechnology

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Company Information

CEOMichael Kazley
Founded2000
IPO DateOctober 26, 2007
Employees14
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNYSEAMERICAN (NYSEAMERICAN)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone510 899 8800
Address
2000 Powell Street, Suite 1150, eleventh floor Emeryville, California 94608 United States

Corporate Identifiers

CIK0001389545
CUSIP66987P201
ISINUS66987P4090
EIN68-0454536
SIC2834

Leadership Team & Key Executives

Michael Kazley
Chief Executive Officer and Director
Tommy Law
Controller, Interim Chief Financial Officer and Treasurer